Trimethylamine-N-oxide acutely increases cardiac muscle contractility

Cardiovascular disease is a major cause of morbidity and mortality among patients with chronic kidney disease (CKD). Trimethylamine-N-oxide (TMAO), a uremic metabolite that is elevated in the setting of CKD, has been implicated as a nontraditional risk factor for cardiovascular disease. While associ...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Am J Physiol Heart Circ Physiol
Prif Awduron: Oakley, Carlee I., Vallejo, Julian A., Wang, Derek, Gray, Mark A., Tiede-Lewis, LeAnn M., Shawgo, Tilitha, Daon, Emmanuel, Zorn, George, Stubbs, Jason R., Wacker, Michael J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Physiological Society 2020
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7346532/
https://ncbi.nlm.nih.gov/pubmed/32243768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00507.2019
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg